Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NNZ-2591
print preview
bookmark
share with colleague
General Information
Company
Neuren Pharmaceuticals Ltd.
Description
Oral diketopiperazine compound, a cyclic dipeptide
Molecular Target
Not available
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Parkinson's disease (PD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy